Kyphon

Quote
I make about 250-300k doing kyphos. It’s a grind to cover all the cases but great facetime and relationships with surgeons that will serve you well no matter where you go afterwards.
 






anonymous said:
would like to know. Job open in my area for interventional
Click to expand...

I would pass unless you’re single and young. You will be a slave to your work. On call, working some weekends. Cases not long but frequent and you are expected to cover each one. No time for vacation. Constantly begging for help with case coverage because the company is too cheap to expand headcount. This is 2022, you could be doing a million other jobs that pay more and allow more flexibility/work life balance. The business is flat yet managers still ride your ass about hitting quotas.
 






























For a division with as much marketshare and relationships as interventional, it is a real shame how out of touch the leadership is from the AVP to VP level, marketing, and customer service. Just absolutely clueless about how to run this organization or retain good talent
 






Either our marketing team is dumber than a bag of rocks, or our company’s leadership set up this division for failure by trying to keep razor thin margins. At what point do you build up safety stock to avoid backorders? At what point do we stop relying on third party vendors who can’t meet deadlines. Why isn’t a global super power like MDT manufacturing this stuff ourselves? We certainly have the demand, we just don’t have the supply! What type of asinine leaders run this division? Our commission plan is hot garbage, structured to retain business, not grow. Ever heard of a spiff? Ever heard of SKU reduction? Maybe incentivize your reps, John McLeod, to sell certain SKU’s that we actually prioritize in manufacturing. Or hire more case coverage bitches so we can actually target new business instead of covering cases all day long like a clinical specialist. Focusing on things that don’t matter like vue cement or kyphon assist is a joke. If you’re really going to push those, at least create a competition to reward those who are selling them. These $100-$300 trinkets aren’t going to make me a dime more on top of my measly $45,000 base salary. Did you see the inflation numbers this year?
 












anonymous said:
Either our marketing team is dumber than a bag of rocks, or our company’s leadership set up this division for failure by trying to keep razor thin margins. At what point do you build up safety stock to avoid backorders? At what point do we stop relying on third party vendors who can’t meet deadlines. Why isn’t a global super power like MDT manufacturing this stuff ourselves? We certainly have the demand, we just don’t have the supply! What type of asinine leaders run this division? Our commission plan is hot garbage, structured to retain business, not grow. Ever heard of a spiff? Ever heard of SKU reduction? Maybe incentivize your reps, John McLeod, to sell certain SKU’s that we actually prioritize in manufacturing. Or hire more case coverage bitches so we can actually target new business instead of covering cases all day long like a clinical specialist. Focusing on things that don’t matter like vue cement or kyphon assist is a joke. If you’re really going to push those, at least create a competition to reward those who are selling them. These $100-$300 trinkets aren’t going to make me a dime more on top of my measly $45,000 base salary. Did you see the inflation numbers this year?
Click to expand...


Nnamdi was the one who fired the GM and really started squeezing - now hes gone, they fired another GM.... this is not going to get better anytime soon.
 






















































David Carr was on his 'apology tour', meeting with docs at SIR and the Fire and Ice rooftop, striving to salvage any of his IR business prospects. The big rumor from SIR is he's eyeing the acquisition of Spine products from Merit, particularly their curved balloon system to compete with Stryker's system and STAR ablation system, for integration into BVNA procedure, following the loss of Relievant to Boston Science. However, David faces a significant hurdle as top sales talent has departed, uninterested in committing to his two-year retention plan for a mere 2% increase in commission. Now that my non-compete is void in MN, why would I want to signed one of these agreements and be locked into this sinking ship?
 












Top Bottom
Back
Quote